The Scotland and Newcastle epidemiological study of Hodgkin’s disease: impact of histopathological review and EBV status on incidence estimates

Aims: The epidemiological and pathological features of Hodgkin lymphoma (HL) are complex. The Epstein-Barr virus (EBV) is consistently associated with a proportion of cases, and these cases are thought to represent a distinct aetiological subgroup of HL. The aim of the present analysis was to determine the age and sex specific incidence of EBV associated and non-associated HL, analysed separately, using data derived from a population based study–the Scotland and Newcastle epidemiological study of Hodgkin’s disease (SNEHD). This study also provided a unique opportunity to evaluate accuracy in the current diagnosis and classification of HL. Methods: SNEHD analysed consecutive cases of HL diagnosed in the study area between 1993 and 1997. Diagnostic biopsy material was retrieved, EBV status of tumours was determined, and histological review was performed. Results: In total, 622 cases were eligible for the study, and EBV studies and histopathological review were performed on biopsy material from 537 and 549 cases, respectively. Accuracy in the overall diagnosis of HL and classification of nodular sclerosis HL was good, but diagnosis of HL in the elderly and classification of other subtypes was less reliable. One third of classic HL cases were EBV associated, and age specific incidence curves for EBV associated and non-associated cases were distinct. Conclusions: Comparison of age specific incidence curves for EBV associated and non-associated HL supports the hypothesis that these are two distinct aetiological entities. Accuracy in the diagnosis of HL is generally good, but certain subgroups of cases continue to present diagnostic difficulties.

[1]  G. M. Taylor,et al.  An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): Evidence for a specific association with EBV+ve HD in young adults , 2003, International journal of cancer.

[2]  E. Jaffe Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .

[3]  F. Alexander,et al.  Hodgkin lymphoma and Epstein‐Barr virus (EBV): No evidence to support hit‐and‐run mechanism in cases classified as non‐EBV‐associated , 2003, International journal of cancer.

[4]  R. Jarrett Viruses and Hodgkin's lymphoma. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  J. Whelan,et al.  A systematic review of the role of pulmonary irradiation in the management of primary bone tumours. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  S. Glaser,et al.  Expert review of the diagnosis and histologic classification of Hodgkin disease in a population‐based cancer registry , 2001, Cancer.

[7]  G. M. Taylor,et al.  Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve). , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  S. Glaser,et al.  Epstein–Barr virus and survival after Hodgkin disease in a population‐based series of women , 2001, Cancer.

[9]  V. Diehl,et al.  European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. , 2000, Blood.

[10]  L. Weiss Epstein-Barr virus and hodgkin’s disease , 2000, Current oncology reports.

[11]  G. M. Taylor,et al.  Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents , 2000, British Journal of Cancer.

[12]  V. Diehl,et al.  Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  D. Wright,et al.  Epstein–Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis , 1998, Leukemia.

[14]  R. Jarrett,et al.  Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease. , 1998, British Journal of Cancer.

[15]  P. Isaacson,et al.  Follicular Hodgkin's disease. , 1995, The American journal of surgical pathology.

[16]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[17]  S. Poppema,et al.  Epstein‐barr virus positivity in hodgkin's disease does not correlate with an hla a2‐negative phenotype , 1994, Cancer.

[18]  D. Jones,et al.  Association of Epstein-Barr virus with pediatric Hodgkin's disease. , 1993, The American journal of pathology.

[19]  K. Hübner,et al.  Classification of Hodgkin's disease biopsies by a panel of four histopathologists. Report of 1,140 patients from the German National Trial. , 1993, Leukemia & lymphoma.

[20]  K. Hübner,et al.  Histopathological classification of Hodgkin's lymphomas. Results from the reference pathology of the German Hodgkin Trial. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  S. Hamilton-Dutoit,et al.  Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease , 1991, The Lancet.

[22]  L. Specht,et al.  Changes over the course of time in histological subclassification of Hodgkin's disease in Denmark. , 1991, Danish medical bulletin.

[23]  S. Glaser,et al.  Time trends in Hodgkin's disease incidence: The role of diagnostic accuracy , 1990, Cancer.

[24]  D. Cunningham,et al.  Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease. , 1986, Journal of clinical pathology.

[25]  A. Bartolucci,et al.  Results of a uniform histopathologic review system of lymphoma cases a ten‐year study from the southeastern cancer study group , 1983, Cancer.

[26]  C. Holman,et al.  Inter‐observer variation in the histopathological reporting of Hodgkin's disease: an analysis of diagnostic subcomponents using kappa statistics , 1983, Histopathology.

[27]  T. Miller,et al.  Mistaken clinical and pathologic diagnoses of Hodgkin's disease: a Southwest oncology group study. , 1982, Cancer treatment reports.

[28]  Woodruff Rd Reviewing histologic diagnosis of lymphoma: comparison of original and review diagnoses in 269 cases. , 1981 .

[29]  Giffen Jw Hodgkin's disease , 1980, Bone Marrow Transplantation.

[30]  J. Holý,et al.  [Epidemiology of Hodgkin's disease]. , 1977, Ceskoslovenska pediatrie.

[31]  C. Coltman,et al.  Histopathologic review of lymphoma cases from the southwest oncology group , 1977, Cancer.

[32]  K. Franssila,et al.  Epidemiology and histopathology of Hodgkin's disease in Finland , 1977, Cancer.

[33]  M. Myers,et al.  International comparability and reproducibility in histologic subclassification of Hodgkin's disease. , 1973, Journal of the National Cancer Institute.

[34]  R. Factor,et al.  Observer disagreement in the classification and histology of Hodgkin's disease. , 1970, Journal of the National Cancer Institute.

[35]  R. Lukes,et al.  The pathology and nomenclature of Hodgkin's disease. , 1966, Cancer research.

[36]  K. Rajewsky,et al.  The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. , 1998, Annual review of immunology.

[37]  Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17-24 June 1997. , 1997, IARC monographs on the evaluation of carcinogenic risks to humans.

[38]  A. Jarrett,et al.  Epidemiology of EBV and Hodgkin's lymphoma. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[39]  E. Alba,et al.  Alternating chemotherapy for small-cell lung cancer. A twelve-week schedule of six drugs. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[40]  G. Roos,et al.  Hodgkin's disease in northern Sweden 1971-1981. I. A histopathological reevaluation of 223 cases. , 1991, Acta oncologica.

[41]  K. Maclennan,et al.  The Clinical and Prognostic Relevance of Histopathologic Classification in Hodgkin’s Disease , 1989 .

[42]  R. Hartsock,et al.  Pathology Panel for Lymphoma Clinical Studies: a comprehensive analysis of cases accumulated since its inception. , 1982, Journal of the National Cancer Institute.

[43]  R. Woodruff Reviewing histologic diagnosis of lymphoma: comparison of original and review diagnoses in 269 cases. , 1981, Archives of pathology & laboratory medicine.

[44]  B. Armstrong,et al.  THE RYE CLASSIFICATION OF A POPULATION BASED SERIES OF HODGKIN'S DISEASE PATIENTS IN WESTERN AUSTRALIA , 1981, Pathology.